Ronit Simantov
Chief Tech/Sci/R&D Officer at GAMIDA CELL LTD.
Net worth: 9 227 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Stephen Brady | M | 54 | 5 years | |
Mike Raab Raab | M | 59 |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | 6 years |
Thomas Woiwode | M | 52 |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | 6 years |
Christine Pellizzari | F | 56 |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | 3 years |
Geoffrey Nichol | M | 69 |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | 5 years |
Justin Trojanowski | M | 36 | 2 years | |
Shantanu Narayen | M | 60 | 11 years | |
Ronald Blaylock | M | 64 | 7 years | |
Sharon Sakai | M | - | - | |
Jim Smith | M | 64 | 10 years | |
Helen Hobbs | M | 71 | 13 years | |
Joseph Echevarria | M | 66 | 9 years | |
Mary Coelho | F | 62 | 1 years | |
Nicholas Maestas | M | 44 | 3 years | |
Darrin Bomba | M | - |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | 3 years |
Bryan Supran | M | - | 8 years | |
Yisrael Gewirtz | M | 47 | - | |
Sam Whiting | M | 58 | 4 years | |
Vladimir Melnikov | M | - | 3 years | |
Steve Danehy | M | - | 12 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
William Steere | M | 88 | 28 years | |
Patrick Mahaffy | M | 61 | 14 years | |
Julian Adams | M | 69 | 8 years | |
Joshua D. Hamermesh | M | 51 | - | |
Shawn Tomasello | F | 65 | 5 years | |
Pierre Lorenzo | M | - | - | |
Ginger Graham | F | 68 | 10 years | |
Yael Margolin | M | 70 | 14 years | |
George A. Lorch | M | 82 | 15 years | |
Abbey Jenkins | F | - | 2 years | |
Heather DiVecchia | F | - | 6 years | |
Amy Schulman | F | 63 | 6 years | |
Paul Gross | M | 59 | 7 years | |
Lindsey Rolfe | M | 56 | 13 years | |
Thomas Dubensky | M | 66 | 6 years | |
Marc Tessier-Lavigne | M | 64 | 4 years | |
Boaz Lifschitz | M | 55 | 5 years | |
Ofer Gonen | M | 50 | 7 years | |
Breanna Burkart | F | - | 14 years | |
Joshua Patterson | M | 48 | 3 years | |
Stephen Wills | M | 67 | 5 years | |
Yi Ning Zhao | M | 53 | 8 years | |
Jaren Madden | F | - | - | |
Richard Fair | M | 55 | 5 years | |
Everett Cunningham | M | 57 | 9 years | |
Keith Flaherty | M | 53 | 10 years | |
Robert Azelby | M | 56 | 5 years | |
Shai Lankry | M | 47 | 5 years | |
Robert Landry | M | 60 | 4 years | |
John Mascotte | M | 84 | 4 years | |
Olivier Brandicourt | M | 68 | 13 years | |
Michael Perry | M | 64 | 4 years | |
Elizabeth A. Whayland | F | 63 |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | 14 years |
Daniel Muehl | M | 61 | 8 years | |
Edward McKinley | M | 72 | 14 years | |
Robert N. Burt | M | 86 | 11 years | |
William Herbert Gray | M | 82 | 13 years | |
M. Anthony Burns | M | 81 | 25 years | |
David Wurzer | M | 65 |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | 10 years |
James Blair | M | 84 | 14 years | |
Paul Klingenstein | M | 68 | 14 years | |
Brian Atwood | M | 71 | 14 years | |
Michael Brown | M | 83 | 16 years | |
Ivan Borrello | M | 60 | 2 years | |
Jeremy Blank | M | 45 | - | |
Kenneth Moch | M | 69 | 8 years | |
Thorlef Spickschen | M | 83 | 14 years | |
David Fox | M | 66 | 1 years | |
Nurit Benjamini | F | 57 | 2 years | |
Tzvi Palash | M | 67 | 3 years | |
David Hering | M | 49 | 6 years | |
James Wassil | M | 54 | 4 years | |
Soma Gupta | F | - | 6 years | |
Reina Benabou | M | 60 | 4 years | |
Clare Khan | M | 72 | 6 years | |
Javier Cote-Sierra | M | 61 | 2 years | |
Hong I. Wan | M | - | 5 years | |
Margaret Marshall | M | 67 | 8 years | |
Premal Patel | M | 54 | 2 years | |
Paulash Mohsen | M | - | 14 years | |
Adrian Woolfson | M | 60 | 3 years | |
Richard Margolin | M | 73 | 2 years | |
Beth Calitri | F | - | 2 years | |
Ian Taylor | M | 61 | 9 years | |
Anna Berkenblit | M | 54 | 4 years | |
Edmund Harrigan | M | 71 | 12 years | |
Vatnak Vat-Ho | M | - | 4 years | |
Torben Nissen | M | 53 | 2 years | |
John Hubbard | M | 67 | 5 years | |
Martine George | M | 76 | 5 years | |
Christine Regan Lindenboom | F | 43 | - | |
Glenn David | M | 52 | 14 years | |
Susan E. Ward | M | - | 2 years | |
Valerie Start | M | 64 | 3 years | |
Cara Cassino | M | 62 | 5 years | |
Baiyong Li | M | 56 | 12 years | |
Feng Guo | M | 54 | 11 years | |
Carl Morris | M | 54 | 5 years | |
William S. Korinek | M | - | 9 years | |
Iain Kilty | M | - | 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 78 | 78.00% |
Israel | 22 | 22.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ronit Simantov
- Personal Network